Skip to content

Therapeutic results of minimal and scattered punch grafting combined with donor site abrasion and topical application of 5-fluorouracil solution in refractory vitiligo lesions

Investigating of outcome minimal scattered punch graft along with donor site abrasion and 5-Fu topical solution in vitiligenous resistant lesions.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250121064470N1
Enrollment
30
Registered
2025-02-04
Start date
2024-09-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. Vitiligo

Interventions

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Stable and resistant vitiligo patients Failure to respond to nonsurgical treatment within 6 months

Exclusion criteria

Exclusion criteria: Presence of other skin diseases such as psoriasis, eczema, infection Patients with allergies to lidocaine Pregnant and breastfeeding women

Design outcomes

Primary

MeasureTime frame
Repigmentation. Timepoint: Three weeks, two months, six months. Method of measurement: Photo before starting the procedure and after completing the treatment.

Secondary

MeasureTime frame
Repigmentation rate. Timepoint: Three weeks, two months, six months. Method of measurement: Before and after treatment photos.;Treatment site and pigmentation improvement. Timepoint: Three weeks, two months, six months. Method of measurement: Before and after treatment photos.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHazhir Mehrabani

Kermanshah University of Medical Sciences

sepehr.amiri1398@gmail.com+98 83 3827 6879

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026